Bias in healthcare AI is not an abstract concern for ethicists to debate at conferences. It is a concrete patient safety problem that is causing measurable harm today. Understanding where this bias comes from, how it manifests, and what can be done about it is essential for anyone involved in developing, deploying, or overseeing AI in healthcare.
Real-World Examples of AI Bias in Healthcare
The examples are sobering and span nearly every domain of medicine. Pulse oximeters — the small devices clipped to fingertips in every hospital — have been shown to systematically overestimate blood oxygen levels in patients with darker skin, a bias that was encoded into AI models trained on their outputs and contributed to delayed treatment during the COVID-19 pandemic. In dermatology, AI diagnostic tools trained predominantly on images of light-skinned patients perform significantly worse when classifying skin conditions in people with darker skin tones, effectively creating a two-tier system of diagnostic accuracy based on race. Perhaps most infamously, a widely used algorithm for allocating healthcare resources was found to systematically deprioritize Black patients because it used healthcare spending as a proxy for healthcare need — and spending is itself shaped by decades of unequal access. In nephrology, the race-based adjustment to the eGFR formula for kidney function meant that Black patients had to be sicker before qualifying for transplant waitlists, a bias that has only recently been addressed.
Root Causes: It Starts with Data
The root causes of AI bias in healthcare are multiple and reinforcing. Training data is the most commonly cited source: if an algorithm learns from datasets that underrepresent certain populations, it will perform poorly on those populations. But the problem runs deeper. Clinical labels themselves can be biased — if historical diagnostic patterns reflect clinician bias (as studies of pain assessment have shown), then an AI trained to replicate those patterns will faithfully reproduce the bias. Proxy variables present another insidious channel: an algorithm that uses zip code, insurance type, or language preference as input features may effectively be using race or socioeconomic status without ever explicitly including those variables. Even the choice of outcome metrics can introduce bias: optimizing for “average accuracy” can mask catastrophic performance gaps in minority subgroups.
Why This Is a Patient Safety Issue
It is tempting to frame AI bias as primarily a fairness or equity concern, and it certainly is that. But reframing it as a patient safety issue is both more accurate and more likely to drive action. When a diagnostic algorithm misses cancers in Black women at twice the rate it misses them in white women, those are missed diagnoses — the same category of harm as a radiologist who fails to read a film properly. When a risk prediction model systematically underestimates the acuity of Hispanic patients, those patients receive less timely care — the same category of harm as a triage error. Patient safety frameworks, incident reporting systems, and quality improvement methodologies all apply directly to AI bias, and healthcare organizations should treat biased algorithms with the same urgency they bring to medication errors or hospital-acquired infections.
Solutions and Frameworks
Addressing bias requires action at every stage of the AI lifecycle. During data collection, teams must audit training datasets for representativeness and actively seek to fill gaps through partnerships with diverse health systems and community organizations. During development, models should be evaluated not just on overall performance but on stratified metrics across demographic subgroups, with predefined thresholds for acceptable performance disparities. Fairness-aware machine learning techniques — including adversarial debiasing, calibration constraints, and resampling strategies — should be part of every development team’s toolkit. During deployment, ongoing monitoring must track performance across populations in real time, with automated alerts when disparities emerge or widen. Frameworks like the NIST AI Risk Management Framework and the WHO’s guidance on ethics and governance of AI for health provide structured approaches, but they only work if organizations commit to implementing them rather than citing them in marketing materials.
The Path Forward
The bias problem in healthcare AI will not be solved by any single intervention. It requires diverse development teams who bring different perspectives to the design process. It requires regulatory bodies that mandate demographic performance reporting. It requires procurement processes that make equity metrics a condition of purchase. It requires clinical champions who refuse to deploy tools without evidence of fair performance. And it requires patients and communities who are informed enough to demand accountability. The good news is that AI, properly developed, can actually reduce the biases present in human clinical decision-making. The path to that future runs directly through the hard, unglamorous work of measuring, reporting, and eliminating the biases in today’s systems.
What Our Experts Think
"Bias in healthcare AI is not hypothetical -- it is documented, measured, and causing harm right now. The pulse oximetry data alone should be a wake-up call: devices that systematically overestimate oxygen levels in dark-skinned patients contributed to delayed treatment during COVID-19. Every AI system built on biased data inherits and often amplifies these inequities."
"The technical roots of bias are well understood: skewed training distributions, label noise from biased clinical practice, and proxy variables that encode race or socioeconomic status. The solutions are also known -- stratified evaluation, fairness constraints, causal modeling. The gap is not knowledge, it is implementation. Most teams ship models without ever running a subgroup analysis."
"This is a leadership issue, not just a technical one. If your AI vendor cannot show you performance metrics broken down by race, age, sex, and socioeconomic status, do not buy their product. Period. The market will only fix this when buyers demand it, and healthcare leaders need to be those demanding buyers."
"I frame bias as a patient safety issue in every boardroom conversation, because that is exactly what it is. A diagnostic algorithm that works well for white males and poorly for Black women is not just unfair -- it is clinically dangerous. When leaders understand that bias is a safety defect, not a political talking point, they allocate resources to fix it."
Ready to Become AI-Ready?
Join our AI Learning Program designed specifically for healthcare professionals. From 1-hour sessions to comprehensive deep dives.